Increased plasma visfatin concentrations in morbidly obese subjects are reduced after gastric banding.
about
Pathophysiology of anorexia in the cancer cachexia syndromeMetabolic surgery: action via hormonal milieu changes, changes in bile acids or gut microbiota? A summary of the literatureEndocrine and Metabolic Effects of Adipose Tissue in Children and AdolescentsVisfatin: a new player in mesangial cell physiology and diabetic nephropathyAdipokines in inflammation and metabolic diseaseInsulin resistance in chronic kidney disease: a systematic review.Changes in neurohormonal gut peptides following bariatric surgery.Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease.Molecular pathways in non-alcoholic fatty liver disease.Human visfatin expression: relationship to insulin sensitivity, intramyocellular lipids, and inflammation.Bone metabolism after bariatric surgery.Visfatin and resistin serum levels in normal-weight and obese women with polycystic ovary syndrome.Obesity as a risk and severity factor in rheumatic diseases (autoimmune chronic inflammatory diseases).Pharmacological and non-pharmacological interventions to influence adipose tissue function.Could the improvement of obesity-related co-morbidities depend on modified gut hormones secretion?Adiposopathy: how do diet, exercise and weight loss drug therapies improve metabolic disease in overweight patients?Visfatin/pre-B-cell colony-enhancing factor: a protein with various suggested functions.Leucocytes are a major source of circulating nicotinamide phosphoribosyltransferase (NAMPT)/pre-B cell colony (PBEF)/visfatin linking obesity and inflammation in humans.Adipokines and proinflammatory cytokines, the key mediators in the pathogenesis of nonalcoholic fatty liver disease.Altered fatty acid metabolism-related gene expression in liver from morbidly obese women with non-alcoholic fatty liver disease.Is PBEF/visfatin/Nampt an authentic adipokine relevant to the metabolic syndrome?Mice deficient in Sfrp1 exhibit increased adiposity, dysregulated glucose metabolism, and enhanced macrophage infiltrationAdipocytokines: The pied pipers.Potential epigenetic mechanism in non-alcoholic Fatty liver diseaseAdipokine gene expression in peripheral blood of adult and juvenile dermatomyositis patients and their relation to clinical parameters and disease activity measuresThe effect of omega-3 on the serum visfatin concentration in patients with type II diabetes.Central obesity, type 2 diabetes and insulin: exploring a pathway full of thorns.Circulating visfatin level and visfatin/insulin ratio in obese women with metabolic syndromeLipid Profiles and Serum Visfatin Concentrations in Patients with Type II Diabetes in Comparison with Healthy Controls.Serum visfatin levels, adiposity and glucose metabolism in obese adolescents.Relationship of visfatin level to pancreatic endocrine hormone level, HOMA-IR index, and HOMA β-cell index in overweight women who performed hydraulic resistance exercise.The effects of omega-3 on blood pressure and the relationship between serum visfatin level and blood pressure in patients with type II diabetesMaternal visfatin concentration in normal pregnancy.Type 2 diabetes mellitus coincident with pulmonary or latent tuberculosis results in modulation of adipocytokinesType 2 diabetes and cardiovascular disease: getting to the fat of the matter.Histopathologic Evaluation of Nonalcoholic Fatty Liver Disease in Hypothyroidism-Induced Rats.Environmental influences on adiponectin levels in humans.Changes in Adipokines following Laparoscopic Roux-en-Y Gastric Bypass Surgery in Chinese Individuals with Type 2 Diabetes Mellitus and BMI of 22-30 kg·m(-2.).The effect of omega-3 supplements on antioxidant capacity in patients with type 2 diabetesNAMPT knockdown attenuates atherosclerosis and promotes reverse cholesterol transport in ApoE KO mice with high-fat-induced insulin resistance.
P2860
Q26775294-624D9554-3DBC-4F58-8689-0219F51A7192Q27010589-C326E6FA-6AB1-4571-9E04-8E04CF642C10Q28082438-6D1466D2-B474-489C-A349-7E3F15A2F3B5Q28577873-CB2869B0-057D-4AF3-9A6E-B61B0E27A855Q29620456-665974B7-C746-4A51-A3A9-1DAC9C5BF043Q30244271-8CEFC910-65FE-4049-ADC8-811652E2C73FQ30391329-4D190FCB-5DE7-4639-8774-1C35AB124AD3Q33580624-8DF58E6D-6320-48AD-9479-57611DF5E00EQ33890230-9F18E8D0-B1B8-4A33-BC34-53E68BD3B24CQ33946323-B5C28484-8E44-4825-BD2D-E87D96421999Q34026645-9363B4DF-3219-410F-9278-D727576C4768Q34197984-75D55E57-D69C-439A-B4AF-84BFBF30AD1AQ34488394-8DFCD3E4-CF80-454C-8B51-376BC16D2157Q34576535-FB6F93A8-AC45-46E3-8401-54ECC1C99610Q34589770-C3D90D05-2F35-4DCB-9FA7-8ADC51EC3066Q34591803-98D5B8E6-5655-48DB-A25B-8B898ECA35F8Q34613425-D614B530-BA76-422D-A10B-A4C9799DAD7FQ34768535-50296EE5-5718-40E9-96EA-8AD57D5F9CC7Q34779049-5CC16EF5-C35E-4368-B6BB-F36B06B48BC8Q34834198-2FF8C591-5F81-48ED-B648-3E7784D7334DQ34993305-24BD35AE-4FCB-4A45-A530-237A67A6F668Q35067279-259D2F0C-9098-48C2-9C0D-7D4334504DB6Q35125469-5E94960F-DC3B-40AF-BD59-AC6AD7922D32Q35380845-7802F1A2-D0A6-470C-9A98-0204730275D1Q35540694-3759D1AA-4C7A-4FAD-BAE6-45394B6D64D2Q35544822-B00D3D02-E749-4EFD-9502-6A606EDD38C1Q35829203-91B38D16-B1FC-4302-BB22-57994C00FC2FQ35990401-69668CB8-5181-431B-8939-2B944EDBB86FQ36022762-6822C07B-3D87-40BB-AFD1-62D2C6410971Q36068142-9190335B-19B8-41A7-9F8E-B477AB73EA64Q36192889-ED2C63B8-DC0A-4DEF-9CF0-C491FE5A2875Q36251404-521A4359-724B-43E3-B407-AE4430A6D9CBQ36406577-93657114-E60A-4EA1-B528-4B2EF9CF380DQ36510376-B017B8E9-129D-4FA0-9B11-2195F1A984A6Q36814772-FB8D388C-9CD0-4DB7-8E83-D50BB1E35164Q36819364-D8F81D54-32A5-443C-BE4A-17CA2EEF702FQ36825618-BF55D9D8-4C5B-4E5F-986F-386E4E89014AQ36838351-1459F15B-0D45-4003-9272-CE3068FB007FQ36917743-A44B7C4F-4396-4D4F-817E-AC08364C2F67Q36941601-58C06A8B-98EF-4B3F-A8AE-76C458B483D1
P2860
Increased plasma visfatin concentrations in morbidly obese subjects are reduced after gastric banding.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Increased plasma visfatin conc ...... reduced after gastric banding.
@ast
Increased plasma visfatin conc ...... reduced after gastric banding.
@en
Increased plasma visfatin conc ...... reduced after gastric banding.
@nl
type
label
Increased plasma visfatin conc ...... reduced after gastric banding.
@ast
Increased plasma visfatin conc ...... reduced after gastric banding.
@en
Increased plasma visfatin conc ...... reduced after gastric banding.
@nl
prefLabel
Increased plasma visfatin conc ...... reduced after gastric banding.
@ast
Increased plasma visfatin conc ...... reduced after gastric banding.
@en
Increased plasma visfatin conc ...... reduced after gastric banding.
@nl
P2093
P356
P1476
Increased plasma visfatin conc ...... reduced after gastric banding.
@en
P2093
Bernhard Ludvik
Dominik G Haider
Georg Schaller
Gerhard Prager
Karin Schindler
P304
P356
10.1210/JC.2005-2248
P407
P577
2006-01-31T00:00:00Z